[go: up one dir, main page]

FI913818A0 - Nytt trombolytiskt aemne. - Google Patents

Nytt trombolytiskt aemne.

Info

Publication number
FI913818A0
FI913818A0 FI913818A FI913818A FI913818A0 FI 913818 A0 FI913818 A0 FI 913818A0 FI 913818 A FI913818 A FI 913818A FI 913818 A FI913818 A FI 913818A FI 913818 A0 FI913818 A0 FI 913818A0
Authority
FI
Finland
Prior art keywords
trombolytiskt
aemne
now
thrombolitic
novel
Prior art date
Application number
FI913818A
Other languages
English (en)
Other versions
FI103577B1 (fi
FI103577B (fi
Inventor
Bertholf Baldus
Peter Donner
Wolf-Dieter Schleuning
Alejandro Alagon
Werner Boidol
Joern Reiner Kraetzschmar
Bernard Jacques Haendler
Gernot Langer
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE3904580A external-priority patent/DE3904580A1/de
Priority claimed from DE19893917949 external-priority patent/DE3917949A1/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of FI913818A0 publication Critical patent/FI913818A0/fi
Application granted granted Critical
Publication of FI103577B1 publication Critical patent/FI103577B1/fi
Publication of FI103577B publication Critical patent/FI103577B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6456Plasminogen activators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Materials For Medical Uses (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI913818A 1989-02-13 1991-08-12 Menetelmä, DNA ja mikro-organismi trombolyyttisen aineen valmistamisek si FI103577B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DE3904580A DE3904580A1 (de) 1989-02-13 1989-02-13 Neues thrombolytikum
DE3904580 1989-02-13
DE19893917949 DE3917949A1 (de) 1989-05-30 1989-05-30 Neues thrombolytikum
DE3917949 1989-05-30
PCT/EP1990/000242 WO1990009438A1 (en) 1989-02-13 1990-02-13 Novel thrombolytic
EP9000242 1990-02-13

Publications (3)

Publication Number Publication Date
FI913818A0 true FI913818A0 (fi) 1991-08-12
FI103577B1 FI103577B1 (fi) 1999-07-30
FI103577B FI103577B (fi) 1999-07-30

Family

ID=25877826

Family Applications (1)

Application Number Title Priority Date Filing Date
FI913818A FI103577B (fi) 1989-02-13 1991-08-12 Menetelmä, DNA ja mikro-organismi trombolyyttisen aineen valmistamisek si

Country Status (16)

Country Link
EP (1) EP0383417B1 (fi)
JP (1) JP2904918B2 (fi)
AT (1) ATE132187T1 (fi)
AU (1) AU642404B2 (fi)
BR (1) BR9007115A (fi)
CA (1) CA2046632C (fi)
DE (1) DE69024382T2 (fi)
DK (1) DK0383417T3 (fi)
ES (1) ES2085326T3 (fi)
FI (1) FI103577B (fi)
GR (1) GR3019328T3 (fi)
HU (1) HU217219B (fi)
IE (1) IE73229B1 (fi)
NO (1) NO308708B1 (fi)
UA (1) UA34415C2 (fi)
WO (1) WO1990009438A1 (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE69054B1 (en) * 1988-07-20 1996-08-07 Schering Ag Vampire bat salivary plasminogen activators
DE3943241A1 (de) * 1989-12-22 1991-06-27 Schering Ag Thrombolytisch wirkendes kombinationspraeparat
DE4442665A1 (de) * 1994-11-30 1996-06-05 Gruenenthal Gmbh Chimäre Proteine mit fibrinolytischen und thrombinhemmenden Eigenschaften
US5731186A (en) * 1996-02-05 1998-03-24 Schering Aktiengesellschaft Method for the production of rDSPA α1
DE10016139A1 (de) * 2000-03-27 2001-10-18 Schleuning Wolf Dieter Verfahren zur Bestimmung von löslichem Fibrin
DE10153601A1 (de) 2001-11-02 2003-05-22 Paion Gmbh DSPA zur Behandlung von Schlaganfall
AU2004240748B2 (en) * 2003-05-21 2010-07-15 Ares Trading S.A. Method of chromatographic analysis of a protein solution
DE10342518A1 (de) * 2003-09-12 2005-05-12 Paion Gmbh Plasminogen-Aktivatoren mit verringerter Lysin-Bindungskapazität
GB0321997D0 (en) 2003-09-19 2003-10-22 Novartis Ag Organic compound
DE202006015207U1 (de) * 2006-05-19 2007-08-16 Paion Deutschland Gmbh Verwendung vn Plasminogenaktivatoren zur Behandlung einer Venenthromboembolie
US8299221B2 (en) 2006-11-17 2012-10-30 Novartis Ag LINGO binding molecules and pharmaceutical use thereof
PL2207808T3 (pl) 2007-11-02 2013-11-29 Novartis Ag Ulepszone cząsteczki wiążące się z Nogo-A i ich zastosowania farmaceutyczne
WO2011107299A2 (en) 2010-04-16 2011-09-09 Paion Deutschland Gmbh Method for the manufacture of recombinant dspa alpha1
US20230399390A1 (en) 2019-10-24 2023-12-14 Novago Therapeutics Ag Novel anti-nogo-a antibodies

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE69054B1 (en) * 1988-07-20 1996-08-07 Schering Ag Vampire bat salivary plasminogen activators

Also Published As

Publication number Publication date
AU5080790A (en) 1990-09-05
CA2046632A1 (en) 1990-08-14
ATE132187T1 (de) 1996-01-15
FI103577B1 (fi) 1999-07-30
IE73229B1 (en) 1997-05-21
FI103577B (fi) 1999-07-30
BR9007115A (pt) 1991-11-26
NO308708B1 (no) 2000-10-16
EP0383417A1 (en) 1990-08-22
EP0383417B1 (en) 1995-12-27
JP2904918B2 (ja) 1999-06-14
IE900506L (en) 1990-08-13
HU217219B (hu) 1999-12-28
WO1990009438A1 (en) 1990-08-23
JPH04504799A (ja) 1992-08-27
HU902004D0 (en) 1991-11-28
NO913129L (no) 1991-10-11
DE69024382T2 (de) 1996-08-14
AU642404B2 (en) 1993-10-21
NO913129D0 (no) 1991-08-12
UA34415C2 (uk) 2001-03-15
CA2046632C (en) 1999-05-11
HUT59724A (en) 1992-06-29
ES2085326T3 (es) 1996-06-01
GR3019328T3 (en) 1996-06-30
DK0383417T3 (da) 1996-05-13
DE69024382D1 (de) 1996-02-08

Similar Documents

Publication Publication Date Title
DK31088D0 (da) Blodkoaguleringsnedsaettende peptidderivater
EP0787802A3 (fi)
EP0335901A4 (en) Methods and compositions for the treatment of non-ige-mediated diseases
DE68916693D1 (de) Molekular-Diagnose von Alzheimer-Krankheit.
ATE358176T1 (de) Menschliche dnase
IT1142032B (it) Preparato che favorisce la coagulazione del sangue a base di proteine umani, nonche' procedimento per la preparazione
ATE411026T1 (de) Mittel zur behandlung der alzheimer-krankheit
FI913818A0 (fi) Nytt trombolytiskt aemne.
EP0376251A3 (en) An anticoagulant substance obtained from urine
IT9041529A1 (it) Dispositivo per la correzione chirurgica dell'ametropia.
IT9041503A0 (it) Dispositivo per la cura chirurgica dell'ametropia
IT8868118A0 (it) Composizione e procedimento per il trattamento e la cura dei capelli
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
ES2073391T3 (es) Metodo y composiciones terapeuticas para el tratamiento de trastornos de perdidas de sangre.
IT8921376V0 (it) Manopola monouso, per l'igiene personale di pazienti in genere.
FI861093A0 (fi) Bioelektrisk patientmonitor.
DE3668338D1 (de) Kontinuierliche behandlung von spannungslosem gewebe.
SE8802323D0 (sv) 8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it
DE68914886D1 (de) Mittel zur Behandlung von Raynaud's Krankheit.
IT8919216A0 (it) Dispositivo per la cura chirurgica dell'astigmatismo.
FI880891A7 (fi) Humaanikudoksen plasminogeenin rekombinanttiaktivaattorin koostumus.
IT8601223A0 (it) Strumento indicatore del grado di abbronzatura dell'epidermide.
ATE65394T1 (de) Behandlung von knochenschwund.
NO900616D0 (no) Fremgangsmaate for fraksjonering av avlinger i industrieltraamateriale.
DE3771706D1 (de) Behandlung von knochenschwund.

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT

Free format text: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT